These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11166713)

  • 1. Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease.
    Sáez-Valero J; Small DH
    Brain Res; 2001 Jan; 889(1-2):247-50. PubMed ID: 11166713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.
    Sáez-Valero J; Fodero LR; Sjögren M; Andreasen N; Amici S; Gallai V; Vanderstichele H; Vanmechelen E; Parnetti L; Blennow K; Small DH
    J Neurosci Res; 2003 May; 72(4):520-6. PubMed ID: 12704813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.
    Sáez-Valero J; Sberna G; McLean CA; Small DH
    J Neurochem; 1999 Apr; 72(4):1600-8. PubMed ID: 10098867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients.
    Gabriel AJ; Almeida MR; Ribeiro MH; Durães J; Tábuas-Pereira M; Pinheiro AC; Pascoal R; Santana I; Baldeiras I
    Neurosci Lett; 2017 Feb; 641():101-106. PubMed ID: 28108398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
    Appleyard ME; McDonald B
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
    Giacobini E; Spiegel R; Enz A; Veroff AE; Cutler NR
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1053-65. PubMed ID: 12111443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholinesterase and butyrylcholinesterase glycoforms are biomarkers of Alzheimer's disease.
    Sáez-Valero J; Small DH
    J Alzheimers Dis; 2001 Jun; 3(3):323-328. PubMed ID: 12214053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.
    Arendt T; Brückner MK; Lange M; Bigl V
    Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
    Parnetti L; Amici S; Lanari A; Romani C; Antognelli C; Andreasen N; Minthon L; Davidsson P; Pottel H; Blennow K; Gallai V
    Neurol Sci; 2002 Sep; 23 Suppl 2():S95-6. PubMed ID: 12548360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.
    Johansson P; Almqvist EG; Johansson JO; Mattsson N; Andreasson U; Hansson O; Wallin A; Blennow K; Zetterberg H; Svensson J
    PLoS One; 2013; 8(11):e81989. PubMed ID: 24312390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.
    Sirviö J; Kutvonen R; Soininen H; Hartikainen P; Riekkinen PJ
    J Neural Transm; 1989; 75(2):119-27. PubMed ID: 2918304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease.
    Sáez-Valero J; Barquero MS; Marcos A; McLean CA; Small DH
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):664-7. PubMed ID: 11032625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo.
    Darreh-Shori T; Forsberg A; Modiri N; Andreasen N; Blennow K; Kamil C; Ahmed H; Almkvist O; Långström B; Nordberg A
    Neurobiol Aging; 2011 Dec; 32(12):2320.e15-32. PubMed ID: 20538374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease.
    Darreh-Shori T; Siawesh M; Mousavi M; Andreasen N; Nordberg A
    J Alzheimers Dis; 2012; 28(2):443-58. PubMed ID: 22012848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities and kinetic properties of lumbar cerebrospinal fluid cholinesterases in relation to clinical diagnosis, severity, and progression of Alzheimer's disease.
    Huff FJ; Reiter CT; Protetch J
    Can J Neurol Sci; 1989 Nov; 16(4):406-10. PubMed ID: 2804802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus.
    Mushtaq G; Greig NH; Khan JA; Kamal MA
    CNS Neurol Disord Drug Targets; 2014; 13(8):1432-9. PubMed ID: 25345511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
    Appleyard ME; Smith AD; Berman P; Wilcock GK; Esiri MM; Neary D; Bowen DM
    Brain; 1987 Oct; 110 ( Pt 5)():1309-22. PubMed ID: 3676702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease.
    Elble R; Giacobini E; Scarsella GF
    Arch Neurol; 1987 Apr; 44(4):403-7. PubMed ID: 3827696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recovery of cerebrospinal fluid acetylcholinesterase activity in Alzheimer's disease patients after treatment with metrifonate.
    Unni L; Vicari S; Moriearty P; Schaefer F; Becker R
    Methods Find Exp Clin Pharmacol; 2000; 22(1):57-61. PubMed ID: 10791297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's disease.
    Huff FJ; Maire JC; Growdon JH; Corkin S; Wurtman RJ
    J Neurol Sci; 1986 Feb; 72(2-3):121-9. PubMed ID: 3711929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.